What is the place of bevacizumab and irinotecan in the treatment of glioblastoma and other malignant gliomas?.

November 13th, 2008 by

admin

Page: 717DOI: 10.1097/WCO.0b013e3283184625Authors: Omuro, Antonio M a; Delattre, Jean-Yves b (Source: Current Opinion in Neurology)

Tags: ATM, Current, glioma

Posted in Cancer |

Related posts

Comments are closed.

Recent Posts

Are the adverse effects of glitazones linked to induced testosterone deficiency?
Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects
The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes
Metabolic syndrome according to different definitions in a rapidly developing country of the African region
Epidemiology of bone tumors in mexico city: retrospective clinicopathologic study of 566 patients at a referral institution.
Sinonasal chondromyxoid fibroma.
Festschrift Issue honoring Judah Folkman, M.D. in Lymphatic Research and Biology
Protein’s essential role in repairing damaged cells revealed
EAU 2nd Eastern Mediterranean Meeting expected to highlight cystectomy
Study links obesity to elevated risk of ovarian cancer

Categories

Archives:

Search: